Jakob Posselt
Interim Chief Financial Officer
Jakob Posselt was appointed interim Chief Financial Officer in January 2026. He joined FUJIFILM Biotechnologies in May 2024 as Senior Vice President of Finance. He brings with him over 20 years of Finance experience in roles of increasing responsibility with Novo Nordisk. He has a Master of Financial Management and Accounting from Aarhus University and Bachelor’s degree International Business from TietgenSkolen.
